On April 28,
Takeda Canada celebrated the first anniversary of its launch in Mississauga with an event at its headquarters. The company has hired 35 people since opening and says it expects to grow its workforce by 200 per cent "in the next few years."
President and General Manager Daaron Dohler said in an announcement of the celebration that the 230-year-old Japanese parent company, Takeda Pharmaceuticals, selected the GTA location for its Canadian operation because of the people it could hire there and work environment. "Takeda
Canada selected Mississauga
for its Canadian headquarters because it is a central location that
offers a sophisticated talent pool, modern healthcare system, leading
medical centres, thriving biotechnology industry and tremendous
scientific expertise and innovation," said Dohler. "Takeda
Canada
is committed to growing our head office team, adding a national sales
force and forging strong, collaborative partnerships with key
stakeholders in order to serve the unmet needs of healthcare providers
and patients in
Canada."
In its one year of operation, according to the company, they "reacquired the commercial rights to type 2 diabetes treatment ACTOS(R)
(pioglitazone HCI) and submitted multiple New Drug Submissions to
Health
Canada." It plans to expand by exploiting its parent company's expertise in diabetes, cardiovascular disease, oncology and gastroenterology.
Writer: Edward Keenan
Source: Laurene Redding, Takeda Canada, Inc.
Got an Innovation & Job News tip? Email [email protected].